This study aimed to further investigate HDAC-inhibitory activity (in vitro and in silico) in more detail and the anticancer activity of CU4c in single and combination treatments, as well as explore its underlying anticancer mechanism against human lung cancer A549 cells both in vitro and in nude mouse xenograft models. The gene discussed is HDAC9; the disease is lung carcinoma.